Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients- 1-year experience from the RIO-Europe study
Version
Download
21
Stock
∞
Total Files
1
Size
160.45 KB
Create Date
4th July 2016
Last Updated
4th July 2016
File
Action
Effects of the cannabinoid 1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients 1 year experience from the RIO Europe study
Tell us what you think